Caption Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Caption Management's BNTX Position: Q1 2026 in Review
Caption Management reduced its BioNTech (BNTX) stake by 36% in Q1 2026, selling an estimated $257K and leaving 4,500 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.
Caption Management first reported a position in BNTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $1.12M in Q2 2020. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.
- Caption Management held 4,500 shares of BioNTech worth $400K as of Q1 2026.
- Caption Management sold 2,500 BioNTech shares in Q1 2026, an estimated $257K.
- BioNTech made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1249 holding.
- Caption Management first reported a position in BioNTech in Q2 2020 and has held it in 6 quarters since.
- Caption Management's BioNTech position peaked at $1.12M in Q2 2020.
- 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.